Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Xylo-Oligosaccharides (XOS) are prebiotics composed of 2–7 β-1,4-linked D-xylose units, including xylobiose, xylotriose, and xylotetraose, derived from plant xylan. They selectively promote beneficial gut bacteria like Bifidobacterium and Lactobacillus, leading to the production of short-chain fatty acids that improve gut microbiota balance and enhance immune function.
Reported Benefits (Provisional)
Origin & History
Xylo-Oligosaccharides (XOS) are a group of prebiotic oligosaccharides derived from xylan, a plant-based polysaccharide found in the cell walls of various plants. As non-digestible fibers, XOS selectively stimulate the growth and activity of beneficial gut bacteria, particularly Bifidobacteria. This targeted action makes XOS a potent functional ingredient for supporting gut health, improving digestive function, and enhancing systemic wellness.
Research Narrative (Provisional)
Numerous human clinical trials and in vitro studies have demonstrated the efficacy of Xylo-Oligosaccharides (XOS) in selectively stimulating beneficial gut bacteria, particularly Bifidobacteria. This robust evidence supports its role in improving gut health, enhancing immune function, and alleviating digestive discomfort, establishing XOS as a well-researched prebiotic.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Carbohydrates: Xylo-Oligosaccharides (non-digestible fiber). - Bioactives: Prebiotic compounds.
Reported Mechanism (Provisional)
Xylo-Oligosaccharides (XOS) function as potent prebiotics by selectively fermenting in the colon, primarily promoting the growth of beneficial gut bacteria such as Bifidobacterium and Lactobacillus. This microbial fermentation produces short-chain fatty acids (SCFAs) like acetate, propionate, and butyrate, which lower colonic pH, inhibit pathogenic bacteria like Escherichia coli, and nourish colonocytes, thereby improving gut barrier function and systemic immunity. This selective stimulation and SCFA production improve gut microbiota balance and reduce digestive discomfort.
Clinical Narrative (Provisional)
Numerous human clinical trials and in vitro studies robustly demonstrate the efficacy of Xylo-Oligosaccharides (XOS) in improving gut health. These studies confirm XOS's selective stimulation of beneficial gut bacteria, particularly Bifidobacterium (100% of strains respond at 0.39 mg/mL), with up to 10-20 times higher potency than fructooligosaccharides (FOS). Key outcomes include enhanced gut microbiota balance, improved immune function via gut-associated lymphoid tissue (GALT) activity, and alleviation of symptoms like constipation and bloating. This evidence supports XOS's role in promoting overall digestive well-being and microbiota modulation.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.